Prevalence of monoclonal gammopathy of undetermined significance.

By R. Kyle, Terry M. Therneau, S. Rajkumar, Dirk R. Larson, M. Plevak, J. Offord, A. Dispenzieri, J. Katzmann, L. Melton. New England Journal of Medicine, 2006

1,319 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/59574f9b9d8d2b16354548bf92ea0b768ea211f8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. S. Rajkumar

In Molecular Biology

1. S. Rajkumar
2. P. Richardson

Citations in the corpus

• Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management (2010, background): “2% of 21,463 residents of Olmsted County, Minnesota, 50 years of age or older (2).”
• Early detection of cancer (2022, neutral): “myeloma (a lethal cancer) of only 1% per year (11), and the risk of Barrett’s esophagus developing into esophageal cancer is ~0.”